Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.04 is 31% above its 5-year average of -1.50, around the middle of its 5-year range (-2.30–-0.11).
20.93% below its 12-month average of -0.86.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.17.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 20 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.04
EARNINGS PER SHARE (EPS) AVG TTM
-0.86
EARNINGS PER SHARE (EPS) AVG 3Y
-1.57
EARNINGS PER SHARE (EPS) AVG 5Y
-1.50
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-20.93%
CURRENT VS 3Y AVG
+33.86%
CURRENT VS 5Y AVG
+30.90%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Century Therapeutics, Inc.
Market Cap
$239.02M
Earnings Per Share (EPS)
-1.04
TTM Avg
-0.86
3Y Avg
-1.57
5Y Avg
-1.50
Market Cap
$239.01M
Earnings Per Share (EPS)
-0.28
TTM Avg
-0.24
3Y Avg
-0.42
5Y Avg
-0.45
Market Cap
$237.57M
Earnings Per Share (EPS)
-0.39
TTM Avg
-0.86
3Y Avg
-1.43
5Y Avg
-1.56
Market Cap
$236.82M
Earnings Per Share (EPS)
-2.38
TTM Avg
-2.11
3Y Avg
-1.81
5Y Avg
-1.81
Market Cap
$241.34M
Earnings Per Share (EPS)
-0.46
TTM Avg
-0.61
3Y Avg
-0.71
5Y Avg
-1.81
Market Cap
$241.39M
Earnings Per Share (EPS)
2.79
TTM Avg
-1.35
3Y Avg
-2.70
5Y Avg
-10.73
Market Cap
$241.94M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.09
3Y Avg
-1.28
5Y Avg
-1.70
Market Cap
$235.97M
Earnings Per Share (EPS)
-0.04
TTM Avg
0.58
3Y Avg
0.64
5Y Avg
0.70
Market Cap
$235.66M
Earnings Per Share (EPS)
-0.11
TTM Avg
-0.18
3Y Avg
-0.30
5Y Avg
-0.87
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | $239.02M | -1.04 | -0.86 | -1.57 | -1.50 |
| High Tide Inc. (HITI)vs › | $239.01M | -0.28 | -0.24 | -0.42 | -0.45 |
| Invivyd, Inc. (IVVD)vs › | $237.57M | -0.39 | -0.86 | -1.43 | -1.56 |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | -2.38 | -2.11 | -1.81 | -1.81 |
| Quantum-Si incorporated (QSI)vs › | $241.34M | -0.46 | -0.61 | -0.71 | -1.81 |
| Q32 Bio Inc. (QTTB)vs › | $241.39M | 2.79 | -1.35 | -2.70 | -10.73 |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | N/A | -1.09 | -1.28 | -1.70 |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | -0.04 | 0.58 | 0.64 | 0.70 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | -0.11 | -0.18 | -0.30 | -0.87 |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | 3.28 | 3.72 | 4.14 | 3.92 |
Trailing EPS (TTM)
$-1.04
Forward EPS (Est.)
$-0.52
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.11 |
| 2024-12-31 | -1.61 |
| 2023-12-31 | -2.30 |
| 2022-12-31 | -2.27 |
| 2021-12-31 | -1.74 |
| 2020-12-31 | -1.00 |
| 2019-12-31 | -4.49 |
